We're excited to announce that we have raised a $3M seed round led by Greg Field, with further participation from Pear VC and continued support from our angel investors.
Pharma brand leads today are surrounded by dashboards and reports - yet still can’t get clear, actionable answers fast enough. That’s exactly the gap Flyway closes.
Instead of giving you another tool, Flyway deploys a coordinated team of AI agents that investigate claims, formulary, and other commercial datasets to uncover what’s blocking your brand’s growth and model the path forward.
All in one week.
We’re building the first autonomous insights engine for pharma. If you have a commercial question you need answered ASAP, we’d love to talk.
Hi, we're Flyway Health and we're excited to announce we've just closed our $3,000,000 seed round. Flyway solves a specific problem for pharma brand leads. Your therapy is growing on a clear trajectory, but you've got a feeling you're not maximizing all your growth potential. And that's where we come in. We deploy our brand tailored AI agents to hunt for those hidden barriers, and we deliver the action plan in one week so you can actually beat your forecast on time. But make no mistake, Flyway is not another dashboard to complicate your existing workflows. And it's not a simple chat bot. It's the first autonomous insights engine for pharma, A coordinated team of agents that interrogate data such as claims formulary or whatever. Else is relevant for your use case. Using our data or yours, Flyway finds the core of what's blocking growth and then models the solution all by itself. What complex problem would you like answered in one week?
Lets goo!!